Shire

Shire, Shionogi File NDA for Intuniv for Adults in Japan
Shire, Shionogi File NDA for Intuniv for Adults in Japan
Yahoo/Zacks.com
Shire
Shionogi
ADHD
Japan
Intuniv
Flag link:
Takeda announces new series of non-core-asset sales
Takeda announces new series of non-core-asset sales
GoinPharma
Takeda
Shire
M&A
Flag link:
Top 10: Takeda’s late-stage pipeline will rely heavily on Shire drugs — but is it worth $62B?
Top 10: Takeda’s late-stage pipeline will rely heavily on Shire drugs — but is it worth $62B?
Endpoints
Takeda
Shire
M&A
Flag link:
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Endpoints
Oyster Point
OC-02
dry eye disease
Allergan
Restasis
Shire
Xiidra
Flag link:
FTC Clears Takeda's Acquisition of Shire
FTC Clears Takeda's Acquisition of Shire
CP Wire
FTC
M&A
Takeda
Shire
Flag link:
More than $100 Billion Spent on M&A in the First 6 Months of 2018
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
M&A
biotech
Celgene
Sanofi
Impact Biomedicines
Bioverativ
GSK
Takeda
Shire
JNJ
Flag link:
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Takeda
Shire
M&A
Japan
Flag link:
Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
Reuters
Takeda
Shire
M&A
shareholders
Flag link:
Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Fierce Pharma
CSL
HAE
Shire
Cinryze
Haegarda
Flag link:
Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Endpoints
Takeda
Shire
Christophe Weber
M&A
Flag link:
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Fierce Pharma
Takeda
Shire
shareholders
M&A
Flag link:
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
RAPS.org
kickbacks
Medicare
physicians
Pfizer
Jazz Pharmaceuticals
Valeant Pharmaceuticals
Shire
Omnicare
Flag link:
Takeda makes $280M divestiture amid Shire buy
Takeda makes $280M divestiture amid Shire buy
Biopharma Dive
Takeda
Shire
M&A
Guangdong Techpool Bio-Pharma
Flag link:
Takeda CEO Sees Path to Survival in Shire Megadeal
Takeda CEO Sees Path to Survival in Shire Megadeal
Bloomberg
Takeda
Shire
M&A
Pharma CEOs
Chris Weber
Flag link:
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Endpoints
Shire
Takeda
M&A
R&D
Flag link:
Takeda and Shire: A Pricey Marriage
Takeda and Shire: A Pricey Marriage
Motley Fool
Takeda
Shire
M&A
Flag link:
Whisky, secrets, and code names: behind-the-scenes of Takeda’s $62B Shire bid – Bloomberg
Whisky, secrets, and code names: behind-the-scenes of Takeda’s $62B Shire bid – Bloomberg
Endpoints
Takeda
Shire
M&A
Flag link:
Takeda to cut IT, marketing and sales jobs after Shire merger
Takeda to cut IT, marketing and sales jobs after Shire merger
Pharmaforum
Takeda
Shire
M&A
layoffs
Flag link:
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Fortune
Takeda
Shire
M&A
Flag link:
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Bloomberg
Takeda
Shire
M&A
Flag link:

Pages